Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference

被引：13
|
作者：
Yanamandra, Uday [1 ]
Khattry, Navin [2 ]
Kumar, Shaji [3 ]
Raje, Noopur [4 ]
Jain, Arihant [1 ]
Jagannath, Sundar [5 ]
Menon, Hari [6 ]
Kumar, Lalit [7 ]
Varma, Neelam [1 ]
Varma, Subhash [1 ]
Saikia, Tapan [8 ]
Malhotra, Pankaj [1 ]
机构：
[1] PGIMER, Dept Internal Med, Chandigarh 160012, India
[2] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India
[3] Mayo Clin, Rochester, MN USA
[4] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[5] Tisch Canc Inst, New York, NY USA
[6] Cytecare Hosp, Bengaluru, India
[7] AIIMS, Dept Med Oncol, New Delhi, India
[8] Prince Aly Khan Hosp, Bombay, Maharashtra, India
来源：
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION | 2017年 / 33卷 / 01期
关键词：
Multiple myeloma; Consensus; Indian scenario; Plasma cell dyscrasia; STEM-CELL TRANSPLANTATION; DIAGNOSIS; THERAPY;
D O I：
10.1007/s12288-016-0773-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/recommendations that can be adapted to the Indian Scenario.
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [41] MANAGEMENT OF MULTIPLE-MYELOMA
    BARLOGIE, B
    BLUT, 1990, 60 (01): : 1 - 7
  • [42] Breakthroughs in the Management of Multiple Myeloma
    Leonard T. Heffher
    Sagar Lonial
    Drugs, 2003, 63 : 1621 - 1636
  • [43] Multiple Myeloma: A Review of the Literature and a Case Report Highlighting the Immunocompromised State of Myeloma Patients
    Nightingale, Brandon
    Decker, Megan
    Ryan, Robert
    Kaczmarczyk, Karolina
    Jandir, Parul
    Waykole, Trupti
    Ashkar, Remi
    Harmon, Gabriella
    Mathur, Ajay
    Levitt, Michael
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (03) : 348 - 354
  • [44] Management of Relapsed and Relapsed/Refractory Multiple Myeloma
    Laubach, Jacob P.
    Mitsiades, Constantine S.
    Mahindra, Anuj
    Luskin, Marlise R.
    Rosenblatt, Jacalyn
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Avigan, David
    Raje, Noopur
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Richardson, Paul G.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (10): : 1209 - 1216
  • [45] Management options for cast nephropathy in multiple myeloma
    Cockwell, Paul
    Hutchison, Colin A.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (06) : 550 - 555
  • [46] Diagnosis and management of multiple myeloma
    Ely, SA
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) : 1194 - 1195
  • [47] The Critical Role of Imaging in the Management of Multiple Myeloma
    Raza, Shahzad
    Leng, Siyang
    Lentzsch, Suzanne
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (03) : 168 - 175
  • [48] Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
    Terpos, Evangelos
    Engelhardt, Monika
    Cook, Gordon
    Gay, Francesca
    Mateos, Maria-Victoria
    Ntanasis-Stathopoulos, Ioannis
    van de Donk, Niels W. C. J.
    Avet-Loiseau, Herve
    Hajek, Roman
    Vangsted, Annette Juul
    Ludwig, Heinz
    Zweegman, Sonja
    Moreau, Philippe
    Einsele, Hermann
    Boccadoro, Mario
    San Miguel, Jesus
    Dimopoulos, Meletios A.
    Sonneveld, Pieter
    LEUKEMIA, 2020, 34 (08) : 2000 - 2011
  • [49] The Prevalence and Management of Multiple Myeloma-Induced Kidney Disease in China
    Shi, Hao
    Chen, Zijin
    Xie, Jingyuan
    Chen, Nan
    KIDNEY DISEASES, 2016, 1 (04) : 235 - 240
  • [50] Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
    Dimopoulos, M. A.
    Palumbo, A.
    Attal, M.
    Beksac, M.
    Davies, F. E.
    Delforge, M.
    Einsele, H.
    Hajek, R.
    Harousseau, J-L
    Leal da Costa, F.
    Ludwig, H.
    Mellqvist, U-H
    Morgan, G. J.
    San-Miguel, J. F.
    Zweegman, S.
    Sonneveld, P.
    LEUKEMIA, 2011, 25 (05) : 749 - 760
12345